The HypoPAST study: evaluation of an online program for Hypoglycaemia Prevention, Awareness of Symptoms and Treatment among adults with type 1 diabetes

Not Applicable

• Conditions: type 1 diabetes; fear of hypoglycaemia; Mental Health - Anxiety; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12623000894695
• Lead Sponsor: Deakin University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-08-21
• Last Update Posted: 28 August 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 196

Inclusion Criteria

Eligible participants will meet all of the following criteria:
1) Adults (18 years or older)
2) Living in Australia
3) Self-reported type 1 diabetes (measured by a study-specific item asking 'What type of diabetes do you have')
4) Self-reported fear of hypoglycaemia (response to a single item from the PAID scale: 'Worrying about low blood glucose reactions' is currently a 'moderate', 'somewhat serious', or 'serious' problem)
5) Access to the internet via one of the following: a) smartphone and laptop/desktop computer, b) smartphone and tablet computer c) tablet computer and laptop/desktop computer

Exclusion Criteria

HypoPAST Steering Group member

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fear of hypoglycaemia worry score, measured with the Hypoglycaemia Fear Survey (HFS-II) worry subscale.[Will be measured at baseline (pre-randomisation), mid-trial (12-weeks post-randomisation) and end-trial (24-weeks post-randomisation). The primary timepoint is end-trial (24-weeks post-randomisation).]